Mechanistic studies in non-small cell lung cancer revealed that GA suppresses tumor angiogenesis by inhibiting the YAP/STAT3 signaling axis, thereby reducing VEGFR2 expression and effectively cutting off the tumor blood supply (Hatami et al., 2020). This evidence concerns the gene KDR and non-small cell lung carcinoma.